L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
Moleculin Biotech, Inc.
Moleculin Biotech, Inc.
Taiho Oncology, Inc.
M.D. Anderson Cancer Center
Assistance Publique - Hôpitaux de Paris
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Beijing InnoCare Pharma Tech Co., Ltd.
Monash University
Monash University
Monash University
Monash University
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Shanxi Bethune Hospital
National University of Malaysia
Institute of Hematology & Blood Diseases Hospital, China
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
University of Giessen
University Hospital, Angers
Monash University
The First Affiliated Hospital of Soochow University
St. Anna Kinderkrebsforschung
The First Affiliated Hospital of Soochow University
The First Affiliated Hospital of Soochow University
Peking University People's Hospital
Hospital Israelita Albert Einstein